They demonstrated that IT injection of these hydrogels increased CD8+ TIL counts, induced tumor regression, prolonged retention of the anti-PD-1 mAb (detectable at 15 days post-injection), and reduced toxicity as no weight loss was observed [131]. Here, CD8A is linked to neoplasm.